Bruderman Asset Management, LLC Abb Vie Inc. Transaction History

Bruderman Asset Management, LLC

$55.7 Million
Q2 2022

A detailed history of Bruderman Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bruderman Asset Management, LLC holds 10,842 shares of ABBV stock, worth $1.86 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

10,842

Previous 11,676 7.14%

Holding current value

$1.86 Million

Previous $1.89 Million 12.26%

% of portfolio

2.98%

Previous 2.86%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $114,775 - $145,916	-834 Reduced 7.14%	10,842 $1.66 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.54 Million - $1.91 Million	-11,673 Reduced 49.99%	11,676 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $4.89 Million - $6.19 Million	-45,508 Reduced 66.09%	23,349 $3.16 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $152,790 - $173,440	1,436 Added 2.13%	68,857 $7.43 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $135,405 - $150,849	1,287 Added 1.95%	67,421 $7.59 Million

Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $178,820 - $196,859	1,748 Added 2.71%	66,134 $7.16 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $1.73 Million - $2.33 Million	21,464 Added 50.01%	64,386 $6.9 Million
Q3 2020 Oct 14, 2020	SELL	$85.91 - $100.83 $187,026 - $219,506	-2,177 Reduced 4.83%	42,922 $3.76 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $62,217 - $83,256	848 Added 1.92%	45,099 $4.47 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $188,598 - $285,937	2,924 Added 7.08%	44,251 $3.25 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $226,848 - $283,836	-3,145 Reduced 7.07%	41,327 $3.7 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2.8 Million - $3.37 Million	44,472 New	44,472 $3.79 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $84,555 - $108,082	-1,287 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $8,485 - $9,986	-110 Reduced 7.87%	1,287 $104,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $80,419 - $99,178	1,033 Added 283.79%	1,397 $129,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $10,402 - $11,564	117 Added 47.37%	364 $34,000
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $25,048 - $29,638	-279 Reduced 53.04%	247 $23,000
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $7.32 Million - $9.8 Million	-79,547 Reduced 99.34%	526 $50,000
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $420,842 - $461,488	-4,699 Reduced 5.54%	80,073 $7.74 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $5.92 Million - $7.56 Million	84,772	84,772 $7.53 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruderman Asset Management, LLC with notifications on news.

Account

Bruderman Asset Management, LLC Abb Vie Inc. Transaction History